The landscape of neuropsychiatric research is undergoing a major shift. For decades, conventional psychiatry has relied on daily medications that target single neurotransmitter pathways, often yielding partial relief for complex conditions. However, a highly unique and complex indole alkaloid derived from the root bark of the West African shrub Tabernanthe iboga is challenging these traditional […]